IL1B and COVID-19: Some mediators were unaltered (IL-1β, IL-33, CCL24, CCL26, IL-5, granulocyte-macrophage colony-stimulating factor [GM-CSF], and IL-10; figure 1B), highlighting less activation during early COVID-19.